General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Marius Pharmaceuticals(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), JAZZ Pharma(MODEST) OTHER FINANCIAL BENEFIT: AstraZeneca Pharmaceuticals(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT), UCB Inc.(SIGNIFICANT), Wolters Kluwers(MODEST)

View Full Disclosure